drugset / Trial / NCT00236392

A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)

NCT00236392

Phase 3 Completed 422 enrolled Janssen Pharmaceutica N.V., Belgium
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of long-term, "on-demand" maintenance therapy with rabeprazole in patients with non-erosive reflux disease (NERD).

Timeline

Start
2001-10
Primary completion
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabeprazole Small molecule 10 mg